Literature DB >> 15083322

A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma.

Helvia Nascimento, Claudio Saddy Rodrigues Coy, Juvenal Ricardo Navarro Góes, Fernando Ferreira Costa, Carmen Silvia Passos Lima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15083322     DOI： 10.1007/s00384-004-0590-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  1 in total

1.  A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.

Authors:  P Iughetti; O Suzuki; P H Godoi; V A Alves; A L Sertié; T Zorick; F Soares; A Camargo; E S Moreira; C di Loreto; C A Moreira-Filho; A Simpson; G Oliva; M R Passos-Bueno
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701
  1 in total
  2 in total

1.  A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies.

Authors:  Xiaopan Wu; Jia Wu; Zhenhui Xin; Huifen Wang; Xilin Zhu; Liping Pan; Zhuo Li; Hui Li; Ying Liu
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

2.  Endostatin gene variation and protein levels in breast cancer susceptibility and severity.

Authors:  Sabapathy P Balasubramanian; Simon S Cross; Jenny Globe; Angela Cox; Nicola J Brown; Malcolm W Reed
Journal:  BMC Cancer       Date:  2007-06-22       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.